Back to Search
Start Over
Fas/FasL expression in tumor biopsies: a prognostic response factor to fluoropyrimidines?
- Source :
-
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2003 Oct; Vol. 28 (5), pp. 403-8. - Publication Year :
- 2003
-
Abstract
- Various studies suggested that cytotoxicity induced by 5-fluorouracil (5-FU) is an apoptotic mechanism possibly mediated by the Fas/FasL system. In this preliminary work, we studied retrospectively the role the Fas/FasL expression as a predictive response factor with fluoropyrimidine-based chemotherapies. We developed a real-time PCR method for measuring Fas and FasL expression in various biopsies from patients treated with a FUFOL-like protocol. No correlation was found between Fas or FasL expression and overall survival or partial response. However, the PCR assay was simple and convenient to use for quantitation of Fas/FasL in tumor biopsies.
- Subjects :
- Adult
Aged
Antimetabolites, Antineoplastic adverse effects
Colonic Neoplasms mortality
Colonic Neoplasms pathology
DNA, Complementary genetics
Fas Ligand Protein
Female
Fluorouracil adverse effects
Humans
Liver Neoplasms secondary
Male
Middle Aged
Polymerase Chain Reaction
Prognosis
Retrospective Studies
Antimetabolites, Antineoplastic therapeutic use
Apoptosis drug effects
Colonic Neoplasms drug therapy
Fluorouracil therapeutic use
Membrane Glycoproteins metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 0269-4727
- Volume :
- 28
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Journal of clinical pharmacy and therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 14632965
- Full Text :
- https://doi.org/10.1046/j.0269-4727.2003.00510.x